<DOC>
	<DOCNO>NCT01736592</DOCNO>
	<brief_summary>The purpose study examine long term safety experimental gene transfer agent , SAR422459 , design treat Stargardt Macular Degeneration .</brief_summary>
	<brief_title>A Study Determine Long Term Safety , Tolerability Biological Activity SAR422459 Patients With Stargardt 's Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Must receive subretinal injection SAR422459 . Must complete protocol TDU13583 Week 48 undergone early discontinuation visit . Did receive SAR422459 part TDU13583 protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>